Equities research analysts expect that II-VI Incorporated (NASDAQ:IIVI) will post sales of $276.99 million for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for II-VI’s earnings. The highest sales estimate is $277.00 million and the lowest is $276.98 million. II-VI posted sales of $231.82 million in the same quarter last year, which would indicate a positive year over year growth rate of 19.5%. The firm is scheduled to announce its next earnings report on Tuesday, January 23rd.

According to Zacks, analysts expect that II-VI will report full-year sales of $276.99 million for the current financial year, with estimates ranging from $1.12 billion to $1.15 billion. For the next financial year, analysts forecast that the firm will report sales of $1.29 billion per share, with estimates ranging from $1.28 billion to $1.30 billion. Zacks’ sales averages are a mean average based on a survey of research analysts that cover II-VI.

II-VI (NASDAQ:IIVI) last posted its quarterly earnings data on Tuesday, October 31st. The scientific and technical instruments company reported $0.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.36 by ($0.04). The company had revenue of $261.50 million during the quarter, compared to the consensus estimate of $255.20 million. II-VI had a net margin of 9.89% and a return on equity of 12.25%. II-VI’s revenue for the quarter was up 18.1% on a year-over-year basis. During the same period in the previous year, the business earned $0.35 earnings per share.

Several brokerages have recently weighed in on IIVI. increased their price target on II-VI from $50.00 to $56.00 and gave the stock a “buy” rating in a report on Wednesday, November 15th. Needham & Company LLC increased their price target on II-VI from $50.00 to $56.00 and gave the stock a “buy” rating in a report on Monday, November 13th. Zacks Investment Research downgraded II-VI from a “buy” rating to a “hold” rating in a report on Tuesday, November 7th. Craig Hallum reiterated a “buy” rating and issued a $58.00 price target (up from $50.00) on shares of II-VI in a report on Wednesday, November 1st. Finally, Benchmark Co. reiterated a “buy” rating and issued a $52.00 price target (up from $44.00) on shares of II-VI in a report on Wednesday, November 1st. One analyst has rated the stock with a sell rating, two have issued a hold rating and six have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $50.64.

In other news, Director Francis J. Kramer sold 25,000 shares of the firm’s stock in a transaction on Tuesday, October 31st. The stock was sold at an average price of $45.10, for a total value of $1,127,500.00. Following the completion of the sale, the director now owns 286,259 shares of the company’s stock, valued at approximately $12,910,280.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Mary Jane Raymond sold 1,000 shares of the firm’s stock in a transaction on Tuesday, October 31st. The stock was sold at an average price of $45.00, for a total value of $45,000.00. Following the completion of the sale, the chief financial officer now directly owns 53,415 shares of the company’s stock, valued at approximately $2,403,675. The disclosure for this sale can be found here. Insiders have sold a total of 51,000 shares of company stock worth $2,222,500 over the last 90 days. 3.80% of the stock is currently owned by company insiders.

Several institutional investors have recently bought and sold shares of IIVI. Pinebridge Investments L.P. boosted its position in shares of II-VI by 1.9% in the 2nd quarter. Pinebridge Investments L.P. now owns 7,237 shares of the scientific and technical instruments company’s stock worth $249,000 after purchasing an additional 137 shares in the last quarter. Piedmont Investment Advisors LLC acquired a new stake in shares of II-VI in the 2nd quarter worth $407,000. SG Americas Securities LLC boosted its position in shares of II-VI by 329.0% in the 2nd quarter. SG Americas Securities LLC now owns 15,112 shares of the scientific and technical instruments company’s stock worth $518,000 after purchasing an additional 11,589 shares in the last quarter. Aperio Group LLC boosted its position in shares of II-VI by 3.6% in the 2nd quarter. Aperio Group LLC now owns 22,586 shares of the scientific and technical instruments company’s stock worth $775,000 after purchasing an additional 784 shares in the last quarter. Finally, Bridge City Capital LLC acquired a new stake in shares of II-VI in the 2nd quarter worth $1,295,000. 79.41% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: “II-VI Incorporated (IIVI) Expected to Post Quarterly Sales of $276.99 Million” was originally reported by American Banking News and is the property of of American Banking News. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright laws. The original version of this piece can be viewed at https://www.americanbankingnews.com/2017/11/21/ii-vi-incorporated-iivi-expected-to-post-quarterly-sales-of-276-99-million.html.

Shares of II-VI (NASDAQ:IIVI) opened at $49.10 on Tuesday. The company has a quick ratio of 2.63, a current ratio of 3.89 and a debt-to-equity ratio of 0.43. II-VI has a fifty-two week low of $27.25 and a fifty-two week high of $49.35. The firm has a market capitalization of $2,980.00, a P/E ratio of 28.80 and a beta of 0.02.

II-VI Company Profile

II-VI Incorporated develops and manufactures engineered materials, optoelectronic components and products. The Company has three segments: II-VI Laser Solutions, II-VI Photonics and II-VI Performance Products. The II-VI Laser Solutions segment designs, manufactures and markets optical and electro-optical components and materials sold under the II-VI Infrared brand name and used in carbon dioxide (CO2) lasers, fiber-delivered beam delivery systems and processing tools and direct diode lasers for industrial lasers sold under the II-VI HIGHYAG and II-VI Laser Enterprise brand names.

Get a free copy of the Zacks research report on II-VI (IIVI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for II-VI (NASDAQ:IIVI)

Receive News & Ratings for II-VI Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for II-VI Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.